Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.1K Sell
23,014
-64,778
-74% -$226K ﹤0.01% 4057
2025
Q4
$330K Buy
87,792
+5,169
+6% +$21.2K ﹤0.01% 4081
2025
Q3
$362K Sell
82,623
-19,288
-19% -$97.6K ﹤0.01% 3989
2025
Q2
$673K Buy
+101,911
New +$599K ﹤0.01% 3583
2024
Q4
Sell
-4,679
Closed -$34.8K 5502
2024
Q3
$34.8K Buy
+4,679
New +$32.5K ﹤0.01% 4816
2024
Q1
Sell
-832
Closed -$5.72K 5397
2023
Q4
$5.72K Hold
832
﹤0.01% 5022
2023
Q3
$4.17K Buy
+832
New +$4.45K ﹤0.01% 4405

Other funds holding VTEX

Barclays's VTEX Position: Q1 2026 in Review

Barclays reduced its VTEX (VTEX) stake by 74% in Q1 2026, selling an estimated $226K and leaving 23,014 shares worth $92.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4057.

Barclays first reported a position in VTEX in Q3 2023 and has held it in 7 quarters since. The position peaked at $673K in Q2 2025. 110 funds tracked by Wall St. Rank hold VTEX as of Q1 2026.

  • Barclays held 23,014 shares of VTEX worth $92.1K as of Q1 2026.
  • Barclays sold 64,778 VTEX shares in Q1 2026, an estimated $226K.
  • VTEX made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4057 holding.
  • Barclays first reported a position in VTEX in Q3 2023 and has held it in 7 quarters since.
  • Barclays's VTEX position peaked at $673K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held VTEX as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.